MHRA authorises GSK’s Omjjara for treating symptoms in adult myelofibrosis with anaemia 31-Jan-2024 By Liza Laws GSK plc’s small molecule Omjjara (momelotinib), was granted marketing authorization (MA) yesterday (January 31) by the Medicines and Healthcare products Regulatory Agency (MHRA).